Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy response
S. Prabhakaran, C. Gatenbee, M. Robertson-Tessi, J. Gray, S. Antonia, A. A. Beg, R. A. Gatenby, A. R. A. Anderson
The paper analyzes multiplexed histological images from NSCLC patients to identify spatial immune ecologies that predict disease progression and serve as potential biomarkers for therapy response.
bioRxiv · Oct 22, 2022 · PreprintCancer Biology